<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>02.00.01. Investigación y comunicación científica</title>
<link href="https://sms.carm.es/ricsmur/handle/123456789/17624" rel="alternate"/>
<subtitle/>
<id>https://sms.carm.es/ricsmur/handle/123456789/17624</id>
<updated>2026-10-24T15:47:16Z</updated>
<dc:date>2026-10-24T15:47:16Z</dc:date>
<entry>
<title>Spanish adaptation of Beers criteria</title>
<link href="https://sms.carm.es/ricsmur/handle/123456789/28824" rel="alternate"/>
<author>
<name>Pastor-Cano, Josep</name>
</author>
<author>
<name>Aranda-García, Ana</name>
</author>
<author>
<name>Rausell-Rausell, Víctor-José</name>
</author>
<author>
<name>Gascón-Cánovas, Juan-José</name>
</author>
<author>
<name>Tobaruela-Soto, Mariana</name>
</author>
<id>https://sms.carm.es/ricsmur/handle/123456789/28824</id>
<updated>2026-10-21T07:52:47Z</updated>
<published>2015-12-01T00:00:00Z</published>
<summary type="text">Spanish adaptation of Beers criteria
Pastor-Cano, Josep; Aranda-García, Ana; Rausell-Rausell, Víctor-José; Gascón-Cánovas, Juan-José; Tobaruela-Soto, Mariana
BACKGROUND: The Beers criteria, which were drawn up in the USA and updated in 2012, were developed to detect potentially inappropriate prescriptions in older adults. Since there are significant differences between the Spanish and North American drug catalogues, our aim was to produce a Spanish adaptation of the criteria. PATIENTS AND METHODS: A comparison of the drugs mentioned in the Beers list with the 2012 Spanish Drugs Catalogue identified those active substances that were on the list in the USA but not commercially available in Spain. We also searched for Spanish drugs that were similar to those listed in the criteria. If these drugs were available in the USA, it was assumed that they had been evaluated by the Beers authors. On the other hand, if similar active substances were not available in the USA, they were evaluated by reference to three information sources: articles reviewed by the American Geriatrics Society in support of the Beers criteria, the product characteristics and information leaflets, and the European STOPP/START, NORGEP and PRISCUS criteria. RESULTS: Of the 199 active substances listed in the Beers criteria, 54 (27.0%) were not commercially available in Spain, but 50 new active substances could be included. These figures differed when "Direct Criteria" were considered: 47 (34.3%) active substances were not commercially available in Spain and 40 new ones could be included in the Beers list. As regards "Disease Dependent Criteria" the figures were 33 (21.3%) and 48, respectively. CONCLUSIONS: A great number of drugs on the Beers list were not commercially available in Spain, and we added many active substances not included in the original version. This study is thus an adaptation of the Beers Criteria to the Spanish health care scenario.
</summary>
<dc:date>2015-12-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Balneotherapy in osteoarthritis</title>
<link href="https://sms.carm.es/ricsmur/handle/123456789/28730" rel="alternate"/>
<author>
<name>Morer, Carla</name>
</author>
<author>
<name>Tenas, Dolors</name>
</author>
<author>
<name>López-Fernández, María-Antonia</name>
</author>
<author>
<name>Maraver, Francisco</name>
</author>
<id>https://sms.carm.es/ricsmur/handle/123456789/28730</id>
<updated>2026-10-21T07:52:47Z</updated>
<published>2015-08-01T00:00:00Z</published>
<summary type="text">Balneotherapy in osteoarthritis
Morer, Carla; Tenas, Dolors; López-Fernández, María-Antonia; Maraver, Francisco
</summary>
<dc:date>2015-08-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Episiotomy and its relationship to various clinical variables that influence its performance</title>
<link href="https://sms.carm.es/ricsmur/handle/123456789/28647" rel="alternate"/>
<author>
<name>Ballesteros-Meseguer, Carmen</name>
</author>
<author>
<name>Carrillo-García, César</name>
</author>
<author>
<name>Meseguer-de-Pedro, Mariano</name>
</author>
<author>
<name>Canteras-Jordana, Manuel</name>
</author>
<author>
<name>Martínez-Roche, María-Emilia</name>
</author>
<id>https://sms.carm.es/ricsmur/handle/123456789/28647</id>
<updated>2026-10-21T07:46:07Z</updated>
<published>2016-01-01T00:00:00Z</published>
<summary type="text">Episiotomy and its relationship to various clinical variables that influence its performance
Ballesteros-Meseguer, Carmen; Carrillo-García, César; Meseguer-de-Pedro, Mariano; Canteras-Jordana, Manuel; Martínez-Roche, María-Emilia
OBJECTIVE: to understand the episiotomy rate and its relationship with various clinical variables. METHOD: a descriptive, cross-sectional, analytic study of 12,093 births in a tertiary hospital. VARIABLES: Parity, gestational age, start of labor, use of epidural analgesia, oxytocin usage, position during fetal explusion, weight of neonate, and completion of birth. The analysis was performed with SPSS 19.0. RESULTS: the global percentage of episiotomies was 50%. The clinical variables that presented a significant association were primiparity (RR=2.98), gestational age &gt;41 weeks (RR=1.2), augmented or induced labor (RR=1.33), epidural analgesia use (RR=1,95), oxytocin use (RR=1.58), lithotomy position during fetal expulsion (RR=6.4), and instrumentation (RR=1.84). Furthermore, maternal age ?35 years (RR=0.85) and neonatal weight &lt;2500 g (RR=0.8) were associated with a lower incidence of episiotomy. CONCLUSIONS: episiotomy is dependent on obstetric interventions performed during labor. If we wish to reduce the episiotomy rate, it will be necessary to bear in mind these risk factors when establishing policies for reducing this procedure.
</summary>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Home enteral nutrition in Region of Murcia, Sample profile, trends and outlook cost From 2007 to 2010</title>
<link href="https://sms.carm.es/ricsmur/handle/123456789/28624" rel="alternate"/>
<author>
<name>Ferrer-Gómez, Mercedes</name>
</author>
<author>
<name>Cuenca-Sánchez, José-Ramón</name>
</author>
<author>
<name>Hernández-Martínez, Antonio-Miguel</name>
</author>
<author>
<name>García-Zafra, María-Victoria</name>
</author>
<author>
<name>Sánchez-Romera, Juan-Francisco</name>
</author>
<author>
<name>Aranda-García, Ana</name>
</author>
<author>
<name>Rausell-Rausell, Víctor-José</name>
</author>
<id>https://sms.carm.es/ricsmur/handle/123456789/28624</id>
<updated>2026-10-21T07:46:07Z</updated>
<published>2016-09-20T00:00:00Z</published>
<summary type="text">Home enteral nutrition in Region of Murcia, Sample profile, trends and outlook cost From 2007 to 2010
Ferrer-Gómez, Mercedes; Cuenca-Sánchez, José-Ramón; Hernández-Martínez, Antonio-Miguel; García-Zafra, María-Victoria; Sánchez-Romera, Juan-Francisco; Aranda-García, Ana; Rausell-Rausell, Víctor-José
Introducción: en Murcia, y hasta 2010, la administración de la nutrición enteral domiciliaria (NED) dictaba cumplir la regulación marcada en cuanto a los facultativos con competencias para su prescripción.Objetivos: examinar aspectos esenciales de este recurso en el periodo 2007-2010, características de la muestra y evolución del coste, así como perspectivas de futuro.Métodos: estudio del perfil de la población NED en un área de salud específica. Selección de recetas facturadas de productos NED en el conjunto de la Región, clasificación por tipos y análisis de la evolución en importe y en envases para el periodo 2007-2010.Resultados: respecto al perfil de la muestra del Área I de Salud de la Región, la patología, vía de administración y tipo de nutrición más frecuentes resultaron, respectivamente, la enfermedad neurológica, la vía oral y la nutrición no específica. Por otro lado, el gasto sanitario en productos dietoterápicos, en el Servicio Murciano de Salud, aumentó alrededor del 50% entre los años 2007 y 2010. Tanto en envases como en importe, Murcia se sitúa por encima de la media nacional.Conclusiones: el perfil de la muestra no coincide con trabajos publicados en otras regiones. Este dato, junto a la posición de Murcia en gasto dietoterápico, y su evidente tendencia al alza en los años analizados, hace evidente la necesidad de medidas que mejoren la calidad de la NED en la Región de Murcia y, en caso de ser posible, conseguir alcanzar valores nacionales en relación con el consumo medio y el gasto.
</summary>
<dc:date>2016-09-20T00:00:00Z</dc:date>
</entry>
</feed>
